COMMUNIQUÉ DE PRESSE publié le 22/10/2025 à 09:00, il y a 9 mois 28 jours Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRÈVE publiée le 16/10/2025 à 11:10, il y a 10 mois 3 jours Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRÈVE publiée le 16/10/2025 à 11:10, il y a 10 mois 3 jours Andera Partners Co-Leads €105 Million Series A for Adcytherix Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
COMMUNIQUÉ DE PRESSE publié le 16/10/2025 à 11:05, il y a 10 mois 3 jours Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRÈVE publiée le 15/10/2025 à 11:15, il y a 10 mois 4 jours Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRÈVE publiée le 15/10/2025 à 11:15, il y a 10 mois 4 jours Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
COMMUNIQUÉ DE PRESSE publié le 15/10/2025 à 11:10, il y a 10 mois 4 jours Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRÈVE publiée le 12/06/2025 à 10:05, il y a 1 année 2 mois Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRÈVE publiée le 12/06/2025 à 10:05, il y a 1 année 2 mois Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
COMMUNIQUÉ DE PRESSE publié le 12/06/2025 à 10:00, il y a 1 année 2 mois Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing
Publié le 18/08/2026 à 18:00, il y a 1 jour KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Publié le 18/08/2026 à 11:15, il y a 1 jour 7 heures GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Publié le 18/08/2026 à 11:15, il y a 1 jour 7 heures GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Publié le 17/08/2026 à 19:45, il y a 1 jour 22 heures Aéroports de Paris S.A - July 2026 traffic figures
Publié le 19/08/2026 à 16:00, il y a 2 heures 38 minutes Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Publié le 19/08/2026 à 15:55, il y a 2 heures 43 minutes Drill Permit Received for Storm Exploration's Gold Standard Project
Publié le 19/08/2026 à 14:40, il y a 3 heures 58 minutes Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Publié le 19/08/2026 à 13:00, il y a 5 heures 38 minutes UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Publié le 19/08/2026 à 13:00, il y a 5 heures 38 minutes Abasca Announces Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit: After-Tax NPV of US$130 Million and 16.7% IRR
Publié le 19/08/2026 à 16:51, il y a 1 heure 46 minutes AUTODOC and Apollo Funds successfully conclude transformative partnership
Publié le 19/08/2026 à 16:15, il y a 2 heures 22 minutes Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Publié le 19/08/2026 à 16:14, il y a 2 heures 23 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc